115 related articles for article (PubMed ID: 31859156)
1. Synthesis and biological evaluation of Vinpocetine derivatives.
Pan BW; Shi Y; Li WC; Wang Q; Pan M; Wu Q; Fu HZ
Bioorg Med Chem Lett; 2020 Jan; 30(2):126472. PubMed ID: 31859156
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Activity Evaluation of Vinpocetine-Derived Indole Alkaloids.
Dong ZC; Shi Y; Zheng LL; Tian YP; Yang J; Wei Y; Zhou Y; Pan BW
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202595
[TBL] [Abstract][Full Text] [Related]
3. A novel PDE1A coupled to M2AChR at plasma membranes from bovine tracheal smooth muscle.
Mastromatteo-Alberga P; Placeres-Uray F; Alfonzo-González MA; Alfonzo RG; Becemberg IL; Alfonzo MJ
J Recept Signal Transduct Res; 2016; 36(3):278-87. PubMed ID: 26513204
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of (nitrooxy)alkyl apovincaminates.
Kawashima Y; Ikemoto T; Horiguchi A; Hayashi M; Matsumoto K; Kawarasaki K; Yamazaki R; Okuyama S; Hatayama K
J Med Chem; 1993 Apr; 36(7):815-9. PubMed ID: 8464035
[TBL] [Abstract][Full Text] [Related]
5. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
[TBL] [Abstract][Full Text] [Related]
7. Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways.
Essam RM; Ahmed LA; Abdelsalam RM; El-Khatib AS
Life Sci; 2019 Apr; 222():245-254. PubMed ID: 30858122
[TBL] [Abstract][Full Text] [Related]
8. Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.
Wu MP; Zhang YS; Xu X; Zhou Q; Li JD; Yan C
Cardiovasc Drugs Ther; 2017 Apr; 31(2):157-166. PubMed ID: 28321644
[TBL] [Abstract][Full Text] [Related]
9. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle.
Hagiwara M; Endo T; Hidaka H
Biochem Pharmacol; 1984 Feb; 33(3):453-7. PubMed ID: 6322804
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of flavonoids as vasorelaxant agents.
Chen Z; Hu Y; Wu H; Jiang H
Bioorg Med Chem Lett; 2004 Aug; 14(15):3949-52. PubMed ID: 15225704
[TBL] [Abstract][Full Text] [Related]
11. Reversal of tolerance to nitroglycerin with vinpocetine: a role of calcitonin gene-related peptide.
Nie SD; Hu CP; Chen YR; Wang S; Deng HW; Li YJ
Int J Cardiol; 2008 Apr; 125(3):436-8. PubMed ID: 17804099
[TBL] [Abstract][Full Text] [Related]
12. Influence of depolarization on vasorelaxant potency and efficacy of Ca2+ entry blockers, K+ channel openers, nitrate derivatives, salbutamol and papaverine in rat aortic rings.
Magnon M; Calderone V; Floch A; Cavero I
Naunyn Schmiedebergs Arch Pharmacol; 1998 Oct; 358(4):452-63. PubMed ID: 9826068
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of vinca alkaloids and related compounds. Part 84. Sulfonamide derivatives of some vinca alkaloids with cardiovascular activity.
Moldvai I; Temesvári-Major E; Szántay C; Tóth G; Kárpáti E; Szántay C
Arch Pharm (Weinheim); 1997 Jun; 330(6):190-8. PubMed ID: 9264244
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta.
Chiu PJ; Tetzloff G; Ahn HS; Sybertz EJ
Am J Hypertens; 1988 Jul; 1(3 Pt 1):262-8. PubMed ID: 2455529
[TBL] [Abstract][Full Text] [Related]
15. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
George RF; Saleh DO
Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
[TBL] [Abstract][Full Text] [Related]
18. [Effect of vinpocetine (TCV-3B), a vasodilator agent, on cyclic nucleotide metabolism].
Hagiwara M; Endo T; Hidaka H
Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):317-23. PubMed ID: 6130034
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of n-butylphthalide derivatives.
Wang W; Cha XX; Reiner J; Gao Y; Qiao HL; Shen JX; Chang JB
Eur J Med Chem; 2010 May; 45(5):1941-6. PubMed ID: 20133025
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of vinpocetine (Cavinton) in dog.
Polgár M; Vereczkey L
Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
